Matthew M. Seavey
Profile
Matthew M.
Seavey is currently a Senior Director-Research at Scorpius Holdings, Inc. Previously, he worked as a Director-Oncology Program at United Therapeutics Corp., a Director-Preclinical Pharmacology at CinRx Pharma LLC, and a Founding Partner at Biopoint Consulting LLC.
He holds a graduate degree from the University of Rochester, an undergraduate degree from the University of Vermont, and an MBA from West Chester University of Pennsylvania.
Former positions of Matthew M. Seavey
| Companies | Position | End |
|---|---|---|
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 01/02/2024 |
| Biopoint Consulting LLC | Corporate Officer/Principal | - |
CinRx Pharma LLC
 CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | - |
| UNITED THERAPEUTICS CORPORATION | Corporate Officer/Principal | - |
Training of Matthew M. Seavey
| Rochester Christian University | Graduate Degree |
| University of Vermont | Undergraduate Degree |
| West Chester University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Linked companies
| Listed companies | 2 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| SCORPIUS HOLDINGS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
CinRx Pharma LLC
CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | Health Technology |
| Biopoint Consulting LLC |
- Stock Market
- Insiders
- Matthew M. Seavey
